Axa
INVA icon

Axa’s Innoviva INVA Stock Holding History

Axa’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35,622
Closed -$716K – 567
2025
Q2 		$716K Buy
35,622
+23,598
+196% +$454K ﹤0.01% 943
2025
Q1 		$218K Buy
+12,024
New +$216K ﹤0.01% 1015
2021
Q3 		– Sell
-92,100
Closed -$1.24M – 1272
2021
Q2 		$1.24M Hold
92,100
– – ﹤0.01% 966
2021
Q1 		$1.1M Hold
92,100
– – ﹤0.01% 963
2020
Q4 		$1.14M Sell
92,100
-30,700
-25% -$331K ﹤0.01% 950
2020
Q3 		$1.28M Sell
122,800
-3,000
-2% -$38.1K ﹤0.01% 890
2020
Q2 		$1.76M Buy
125,800
+63,600
+102% +$865K 0.01% 850
2020
Q1 		$731K Buy
+62,200
New +$823K ﹤0.01% 912
2014
Q3 		– Sell
-82,138
Closed -$2.45M – 1460
2014
Q2 		$2.45M Sell
82,138
-151,135
-65% -$3.62M 0.01% 725
2014
Q1 		$5.82M Buy
233,273
+12,148
+5% +$356K 0.03% 493
2013
Q4 		$6.35M Buy
221,125
+10,999
+5% +$322K 0.03% 475
2013
Q3 		$6.92M Buy
210,126
+45,763
+28% +$1.42M 0.03% 447
2013
Q2 		$5.1M Buy
+164,363
New +$4.41M 0.03% 479

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Axa's INVA Position: Q3 2025 in Review

Axa sold out of Innoviva (INVA) in Q3 2025, closing a stake of 35,622 shares — an estimated $716K sold.

Axa first reported a position in INVA in Q2 2013 and held it in 13 quarters. The position peaked at $6.92M in Q3 2013. 264 funds tracked by Wall St. Rank hold INVA as of Q3 2025.

  • Axa reported no remaining Innoviva position as of Q3 2025 after selling out during the quarter.
  • Axa sold 35,622 Innoviva shares in Q3 2025, an estimated $716K.
  • Axa first reported a position in Innoviva in Q2 2013 and held it in 13 quarters.
  • Axa's Innoviva position peaked at $6.92M in Q3 2013.
  • 264 funds tracked by Wall St. Rank held Innoviva as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.